Literature DB >> 19411394

Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.

Sarah Ringold1, Carol A Wallace, Frederick P Rivara.   

Abstract

OBJECTIVE: To compare child self-report and parent/proxy report of health-related quality of life (HRQOL), disability, and fatigue in children with active polyarticular juvenile idiopathic arthritis (JIA) to that of children with inactive polyarticular JIA and to previous data from healthy controls.
METHODS: Cross-sectional survey of children with polyarticular JIA diagnosed and treated between 2000 to 2006 and their parent/proxy. The Childhood Health Assessment Questionnaire, Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales, PedsQL Rheumatology Module, and PedsQL Multidimensional Fatigue Scale were administered. Disease activity data were collected from the physician clinic notes. Comparisons were performed with t tests. Correlations between patient and parent/proxy reports were measured with Pearson correlation coefficients.
RESULTS: Sixty children and/or their parents/proxies participated (79% response rate). Disease activity status was available for 52, and 32 met criteria for inactive disease (62%). Participants reported lower scores on the PedsQL Generic Core Scales (range 2.54-9.13 points lower) and the PedsQL Rheumatology Module (range 2.46-6.96 points lower) than those with inactive disease. Participants also reported lower scores on the PedsQL Multidimensional Fatigue Scale than did healthy controls, regardless of disease activity status (range 0.06-9.2 points lower).
CONCLUSION: Although children in this cohort with polyarticular JIA and inactive disease reported HRQOL scores similar to those of healthy controls, children with polyarticular JIA and their parents/proxies tended to report more fatigue than controls, regardless of disease activity. Application of these measures prospectively to larger cohorts of children with JIA is needed to assess these differences.

Entities:  

Mesh:

Year:  2009        PMID: 19411394     DOI: 10.3899/jrheum.081028

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

1.  Congruence between polysomnography obstructive sleep apnea and the pediatric sleep questionnaire: fatigue and health-related quality of life in juvenile idiopathic arthritis.

Authors:  Teresa M Ward; Maida Lynn Chen; Carol A Landis; Sarah Ringold; Dean W Beebe; Kenneth C Pike; Carol A Wallace
Journal:  Qual Life Res       Date:  2016-12-16       Impact factor: 4.147

2.  2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Authors:  Sarah Ringold; Sheila T Angeles-Han; Timothy Beukelman; Daniel Lovell; Carlos A Cuello; Mara L Becker; Robert A Colbert; Brian M Feldman; Polly J Ferguson; Harry Gewanter; Jaime Guzman; Jennifer Horonjeff; Peter A Nigrovic; Michael J Ombrello; Murray H Passo; Matthew L Stoll; C Egla Rabinovich; Rayfel Schneider; Olha Halyabar; Kimberly Hays; Amit Aakash Shah; Nancy Sullivan; Ann Marie Szymanski; Marat Turgunbaev; Amy Turner; James Reston
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04-25       Impact factor: 4.794

3.  2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Authors:  Sarah Ringold; Sheila T Angeles-Han; Timothy Beukelman; Daniel Lovell; Carlos A Cuello; Mara L Becker; Robert A Colbert; Brian M Feldman; Polly J Ferguson; Harry Gewanter; Jaime Guzman; Jennifer Horonjeff; Peter A Nigrovic; Michael J Ombrello; Murray H Passo; Matthew L Stoll; C Egla Rabinovich; Rayfel Schneider; Olha Halyabar; Kimberly Hays; Amit Aakash Shah; Nancy Sullivan; Ann Marie Szymanski; Marat Turgunbaev; Amy Turner; James Reston
Journal:  Arthritis Rheumatol       Date:  2019-04-25       Impact factor: 10.995

4.  Factorial invariance of pediatric patient self-reported fatigue across age and gender: a multigroup confirmatory factor analysis approach utilizing the PedsQL™ Multidimensional Fatigue Scale.

Authors:  James W Varni; A Alexander Beaujean; Christine A Limbers
Journal:  Qual Life Res       Date:  2013-02-20       Impact factor: 4.147

5.  Determinants of health-related quality of life impairment in Egyptian children and adolescents with juvenile idiopathic arthritis: Sharkia Governorate.

Authors:  Amal B Abdul-Sattar; Enass A Elewa; Eman El-Dessoky El-Shahawy; Eman H Waly
Journal:  Rheumatol Int       Date:  2014-01-28       Impact factor: 2.631

6.  Lower extremity pain is associated with reduced function and psychosocial health in obese children.

Authors:  Sharon Bout-Tabaku; Matthew S Briggs; Laura C Schmitt
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

7.  Burden of childhood-onset arthritis.

Authors:  Lakshmi N Moorthy; Margaret Ge Peterson; Afton L Hassett; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

Review 8.  Health-related quality of life and symptom reporting: similarities and differences between children and their parents.

Authors:  Christine Eiser; James W Varni
Journal:  Eur J Pediatr       Date:  2013-05-29       Impact factor: 3.183

Review 9.  Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.

Authors:  Emily von Scheven; Kathleen Jo Corbin; Stefano Stagi; Stagi Stefano; Rolando Cimaz
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

10.  Fatigue in children with juvenile idiopathic arthritis: reliability of the "Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale".

Authors:  Luciana Tudech S P Paulo; Claudio A Len; Maria Odete E Hilario; Soraya A Pedroso; Maria Sylvia S Vitalle; Maria Teresa Terreri
Journal:  Rheumatol Int       Date:  2014-06-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.